Emicizumab, also known as ART-101 is representing a crucial advancement in hemophilia these genetic disease . This novel factor functions as a prothrombin molecule, substituting for factor VIII, a https://lawsonroxr943617.aboutyoublog.com/51796803/introducing-breakthrough-for-bleeding-disorders-treatment